Only 1 percent of the jobs given to Texas-based Merritt Hawkins over the past year were for solo practitioners, the physician recruiting firm reported this month. That’s down from 22 percent of all searches in 2004.
A little extra Medicare money will flow to suburban hospitals in the Indianapolis area, based on recent patient satisfaction scores. But hospitals in the core of Indianapolis—and hospitals that do significant amounts of teaching medical students—may take a hit.
A troubled central Indiana nuclear medicine company is dropping plans to build a multimillion-dollar facility in Noblesville after reaching a better deal with the city of Gary.
Hospital system’s health insurance unit has IT infrastructure that will allow physicians to participate in Medicare’s shared savings program.
MaxIT’s 1,300 employees, who provide information technology services to hospitals and physician practices, will join Virginia-based Science Applications International Corp.
Gov. Mitch Daniels says he plans to ask his potential successors whether the state should set up a health care exchange.
For the first time, Indiana University Health has been named to U.S. News & World Report's "Best Hospitals Honor Roll," a distinction that goes to the top medical centers in the country.
The immediate reaction on Wall Street to last month’s U.S. Supreme Court ruling upholding President Obama’s health care law was to buy hospital stocks and dump health insurance stocks. But at least one analyst expects the long-term outcome to be the exact opposite.
Eli Lilly and Co. got a boost of confidence last week that its project to launch the first effective Alzheimer’s treatment is on the right track—though it still faces hugely long odds.
Indiana University says an accrediting agency has approved its request to begin the accreditation process for the Schools of Public Health proposed for its Bloomington and Indianapolis campuses.
The buying spree is back on at WellPoint Inc., with a twist. A decade ago, the insurer consolidated Blue Cross and Blue Shield plans that catered to employers. Today, it is making deals to grow the non-employer part of its business.
WellPoint Inc. said it will pay for DNA testing for three children to see if they have an inherited heart disease their father suffers from that often strikes without warning, reversing an earlier decision to deny coverage.
Eli Lilly and Co. said a potential treatment for acute schizophrenia failed in a late-stage study that compared patients taking the drug to those taking a placebo.
Johnson & Johnson, Pfizer Inc. and Elan Corp are racing Indianapolis-based Eli Lilly and Co. to market the first broadly available drug designed to target a cause of Alzheimer’s, rather than just its symptoms. Analysts say the potential drugs are long shots.
A chain of dental offices that abruptly closed multiple Indiana locations in December 2010 left patients without care, refunds or records, according to a complaint filed by the Office of the Indiana Attorney General.
Indiana University Health, as well as a partnership of Franciscan Alliance and American Health Network, have formed accountable care organizations that won the blessing of the federal Medicare Shared Savings program.
With spending running well ahead of revenue, West Lafayette-based Bioanalytical Systems Inc. ousts its CEO in favor of its CFO.
Investors and analysts like the fact that WellPoint is playing more aggressively in government-sponsored health plans, such as Medicaid and Medicare, which are projected to be the key sectors for growth for the next several years.
The Indianapolis health insurer is buying Virginia-based Amerigroup Corp. to expand in managed care for poor and elderly patients in the Medicare and Medicaid programs.
Eli Lilly and Co. said Friday that it has received an extra six months of marketing exclusivity on the antidepressant Cymbalta, its biggest selling drug. The extension could mean more than a billion dollars in sales for the Indianapolis drug maker.
